Windlas Biotech IPO is going to hit the market on 04 Aug 2021 and closes on 06 Aug 2021. The company to raise ₹401.54 crores (approx) via initial public offer with a face value of ₹5 per equity share.


Windlas Biotech IPO is going to hit the market on 04 Aug 2021 and closes on 06 Aug 2021. Windlas Biotech IPO open on Wednesday fixed a price band of Rs448-460 a share for its Rs401.54 crore (approx) IPO. The face value of equity shares of Windlas Biotech IPO is ₹5. Windlas Biotech company to raise ₹ cr via an initial public offer that comprises ₹165 crores of fresh issue and ₹ crores of an offer for sale. Incorporated in 2001, Windlas Biotech Ltd is one of the leading companies in the pharmaceutical formulations contract development and manufacturing organizations (CDMO) segment in India. The company offers a range of CDMO services from product discovery to product development, licensing, and commercial manufacturing of generic products including complex generics. Check out Windlas Biotech IPO details.

    Windlas Biotech IPO

    Windlas Biotech IPO Date & Price Band:

    IPO Opening Date Aug 4, 2021
    IPO Closing Date Aug 6, 2021
    Issue Type Book Built Issue IPO
    Face Value ₹5 per equity share
    IPO Price ₹448 to ₹460 per equity share
    Market Lot 30 Shares
    Min Order Quantity 30 Shares
    Listing At BSE, NSE
    Issue Size [.] Eq Shares of ₹5
    (aggregating up to ₹401.54 Cr)
    Fresh Issue [.] Eq Shares of ₹5
    (aggregating up to ₹165 Cr)
    Offer for Sale 51,42,067 Eq Shares of ₹5
    (aggregating up to ₹236.54 Cr)

    Windlas Biotech IPO Tentative Timetable

    The Windlas Biotech IPO open date is 4 Aug 2021, and the close date is 6 Aug 2021. The issue may list on. 
    IPO Open Date Aug 4, 2021
    IPO Close Date Aug 6, 2021
    Basis of Allotment Date Aug 11, 2021
    Initiation of Refunds Aug 12, 2021
    Credit of Shares to Demat Account Aug 13, 2021
    IPO Listing Date Aug 17, 2021

    Windlas Biotech IPO Market Lot:

    The Windlas Biotech IPO minimum market lot is 30 shares with ₹13,800 application amount. The retail investors can apply up to 14 lots with 420 shares or ₹193,200 amounts.

    Minimum Lot Size: Minimum 30 Shares
    Minimum Amount: ₹13,800
    Maximum Lot Size: Maximum 420 Shares
    Maximum Amount: ₹193.200

    Windlas BiotechCompany Financial:

    Particulars For the year/period ended (₹ in million)
    31-Dec-20 31-Mar-20 31-Mar-19 31-Mar-18
    Total Assets 3,158.83 3,384.88 2,981.80 2,898.87
    Total Revenue 3,230.94 3,313.39 3,115.25 3,565.76
    Profit After Tax 96.74 162.13 638.22 111.98
    Read Also:- 

    Windlas Biotech IPO Form:

    How to apply the Windlas Biotech IPO? You can apply for Windlas Biotech IPO via ASBA available in your bank account. Just go to the online bank login and apply via your bank account by selecting the Windlas Biotech IPO in the Invest section. The other option is you can apply to Windlas Biotech IPO via IPO forms download via NSE and BSE. Check out the Windlas Biotech IPO forms – click NSE Forms & BSE Forms blank  IPO forms download, fill, and submit in your bank or with your broker.

    Windlas Biotech IPO Subscription Numbers
    (Day 1)

    Category Day 1 Day 2 Day 3
    QIB x x x
    NII x x x
    RII x x x
    EMP x x x
    OTH x x x
    Total x x x

    About Windlas Biotech

    Founded in the year 2001, Windlas Biotech provides pharmaceutical development services, large-scale manufacturing services, and authentic yet affordable products to its customers and consumers around the world.
    We employ 954 employees at our four state-of-the-art manufacturing facilities in Dehradun, Uttarakhand India. We also have a salesforce and distribution network spread across 14 states. We market our own manufactured authentic nutraceutical, pharmaceutical and ayurvedic products to serve the semi-urban and rural communities at affordable prices. “The registered name of the company is Windlas Biotech Limited (Formerly known as Windlas Biotech Private Limited).”
    Innovation is at the core of our spirit at Windlas. We aim to deliver customized, innovative, and complex generic products to our customers. Our R&D team works closely with customers or prospective customers and provides innovative and cost-efficient solutions tailored to meet specific customer requirements. When we work on a customer-specific project then the customers also oversee the planning and execution of our projects. Our R&D team oversees the transfer of technology from lab scale to plant scale and prepares backup strategies. Thereafter, we scale up our operations from the R&D stage to large-scale manufacturing. We emphasize maintaining consistency in the quality of our products as well as planning and executing projects in a timely manner.
    We are constantly focused on improving the efficiency of our operations and increasing the value of our research and manufacturing services to our clients. We are proud of our undeterred focus on quality and compliance assurance systems that provide authentic, efficacious, and safe products to all patients consuming our products. Our dedication to quality can be seen from the fact that almost 40% of our staff workforce is in Quality Control / Quality Assurance functions.

    Windlas Biotech IPO Prospectus

       

    Windlas Biotech Company Promoters:

    • Ashok Kumar Windlass
    • Hitesh Windlass
    • Manoj Kumar Windlass
    • AKW WBL Family Pvt Trust

    Windlas Biotech IPO Registrar:

    Link Intime India Private Ltd
    C 101, 247 Park, L.B.S.Marg,
    Vikhroli (West), Mumbai – 400083
    Phone: +91-22-4918 6270
    Email: windlas.ipo@linkintime.co.in
    Website: http://www.linkintime.co.in

    Windlas Biotech IPO Lead Managers: 

    • DAM Capital Advisors Ltd (Formerly IDFC Securities Ltd)
    • IIFL Holdings Limited
    • SBI Capital Markets Limited

    Windlas Biotech Company Address: 

    Windlas Biotech Limited
    40/1, Mohabewala Industrial Area,
    Dehradun, 248110
    Phone: +91 135 6608000
    Email: grievance@windlasbiotech.com
    Website: http://www.windlasbiotech.com/


    Windlas Biotech IPO FAQs

    What is Windlas Biotech IPO?

    Windlas Biotech IPO is a main-board IPO. They are going to raise ₹401.54 Crores via IPO. The issue is priced at ₹448 to ₹460 per equity share. The IPO is to be listed on BSE & NSE.


    When Windlas Biotech IPO will open?

    The Windlas Biotech IPO is to open on 04 Aug 2021 for QIB, NII, and Retail Investors.


    What is Windlas Biotech IPO Investors Portion?

    The investors’ portion for Rolex Rings Limited IPO is QIB 50%NII 15%, and Retail 35%.


    How to Apply the Windlas Biotech IPO?

    You can apply for Windlas Biotech IPO via ASBA online via your bank account. You can also apply for ASBA online via UPI through your stock brokers. You can also apply via your stock brokers by filling up the offline form.


    How to Apply the Windlas Biotech IPO through Zerodha?

    Log in to Console in Zerodha Website. Go to Portfolio and Click on IPO. You will see the IPO Name “Windlas Biotech”. Click on Bid Button. Enter your UPI ID, Quantity, and Price. Submit IPO Application Form. Now go to your UPI App on Net Banking or BHIM App to Approve the mandate.


    What is Windlas Biotech IPO Size?

    Windlas Biotech IPO size is ₹401.54 crores (Approx).

    What is Windlas Biotech IPO Price Band?

    Windlas Biotech IPO Price Band is ₹448 to ₹460.

    What is Windlas Biotech IPO Minimum and Maximum Lot Size?

    The minimum bid is 30 Shares with ₹13,800 amount while the maximum bid is 420 shares with ₹1,93,200.

    What is Windlas Biotech IPO Allotment Date?

    Windlas Biotech IPO allotment date is 11 Aug 2021.

    What is Windlas Biotech IPO Listing Date?

    Windlas Biotech IPO listing date is 17 Aug 2021. The IPO to list on BSE and NSE. 

    Leave a Reply

    Your email address will not be published. Required fields are marked *